Strategic Perspectives: Pancreatic Cancer - Gemcitabine Combination Therapy is the Future - Market Research Reports

Welcome - Home - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.

Advanced


	Select a currency for use throughout the site

Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying

| More

Hard Copy
Electronic

Strategic Perspectives: Pancreatic Cancer - Gemcitabine Combination Therapy is the Future
Datamonitor, Nov 2002, Pages: 125



		Description



		Table of Contents



		Enquire before Buying


	Send to a Friend

Send to a Friend

To email a friend details of Strategic Perspectives: Pancreatic Cancer - Gemcitabine Combination Therapy is the Future complete the form below and click on "Send".

* Required Information

Your Friend's Details

Friend's Full Name *

Friend's Email Address *

A message for your Friend

Your Contact Details

Your Name *

Email Address *

Customers who bought this item also bought

Pancreatic Cancer - Gold Standard Gemcitabine Waiting to be Challenged

Niche Cancers 2001: Pancreatic Cancer

Cancer Pancreatic Cancer

Stakeholder Opinions: Pancreatic Cancer - Gemzar Dominance will Continue among High Levels of Persistent Unmet Needs

Drugs of Tomorrow: Cancer Overview

Treatment Algorithms 2001 Breast Cancer: Herceptin Falling into Stride

Drugs of Tomorrow: Cancer Overview - The synergistic advance: innovatives compliment traditional chemotherapies

Br Malls Participacoes Sa

Br. Holdings Corporation

Strategic Perspectives 2002: Colorectal Cancer Cost Analysis

Drugs of Tommorow 2002: Breast Cancer

Chinese Markets for Polybutadiene Rubber (BR)

Top of page